Notice of Meetings, 3850-3851 [06-611]
Download as PDF
<![CDATA[
3850
Federal Register / Vol. 71, No. 15 / Tuesday, January 24, 2006 / Notices
Rockville, MD 20850, Fax:
301.427.1597, E-mail: tmiller@ahrg.gov.
FOR FURTHER INFORMATION CONTACT:
Therese Miller at tmiller@ahrq.gov or
Gloria Washington at
gwashing@ahrq.gov.
Arrangement For Public Inspection:
All nominations will be available for
public inspections by appointment at
the Center for Primary Care, Prevention
& Clinical Partnerships, 301.427.1500,
weekdays between 10 a.m. and 5 p.m.
(eastern time).
SUPPLEMENTARY INFORMATION:
Background
Under Title IX of the Public Health
Service Act, AHRQ is charged with
enhancing the quality, appropriateness
and effectiveness of health care services
and access to such services. AHRQ
accomplishes these goals through
scientific research and promotion of
improvements in clinical practice,
including prevention of diseases and
other health conditions and
improvements in the organization,
financing and delivery of health care
services (42 U.S.C. 299–299c–7 as
amended by Pub. L. 106–129 (1999)).
The United States Preventive Services
Task Force (USPSTF) is an independent
expert panel, first established in 1984
under the auspices of the U.S. Public
Health Service. Currently, under
AHRQ’s authorizing legislation noted
above, the Director of AHRQ is
responsible for convening the USPSTF
to be composed of individuals with
appropriate expertise. The mission of
the Task Force is to rigorously evaluate
the effectiveness of critical preventive
services and to formulate
recommendations for primary care
clinicians regarding the appropriate
provision of preventive services. The
USPSTF transitioned to a standing Task
Force in 2001. Current Task Force
recommendations and associated
evidence reviews are available at
https://www.preventiveservices.ahrq.gov.
rmajette on PROD1PC67 with NOTICES1
Topic Nomination Solicitation
The purpose of this solicitation for
new topics by AHRQ and the USPSTF
is to create a balanced portfolio of
relevant topics for the current Task
Force library. The library is based on
populations, types of services
(screening, counseling, preventive
medications), and disease types (cancer;
heart and vascular disease; injury and
violence-related disorders; infectious
diseases; mental disorders and
substance abuse; metabolic, nutritional
and endocrine diseases; musculoskeletal
conditions; obstetric and gynecological
conditions; pediatric disorders; and,
VerDate Aug<31>2005
14:44 Jan 23, 2006
Jkt 208001
vision and hearing disorders). Selection
of suggested topics will be made on the
basis of qualifications of nominations as
outlined above (see basic topic
nomination requirements) and the
current expertise of the USPSTF.
U.S. Preventive Services Task Force
Type of
preventive
service
Topics Currently Under Review:
Additional Risk Factors for Intermediate CHD Risk.
Aspirin Primary Prevention of
CHD.
Aspirin Prophylaxis in Pregnancy.
Aspirin/NSAIDs to prevent
Colorectal Cancer.
Bacterial Vaginosis in Pregnancy.
Breast Cancer .........................
Carotid Artery Stenosis ...........
Chlamydial Infection ................
Colorectal Cancer ...................
Depression in Adults ...............
Drug Misuse ............................
Dyslipidemia in Adults and
Children.
Gestational Diabetes Mellitus
Hearing Impairment in Elderly
Hearing Impairment Newborn
Hemochromatosis ...................
Hip Dysplasia ..........................
HIV & Other Sexually Transmitted Diseases.
Iron Deficiency Anemia, including iron prophylaxis.
Lead Levels in Childhood &
Pregnancy.
Motor Vehicle Occupant Injuries.
Obesity in Adults .....................
Osteoporosis to prevent Fractures.
Skin Cancer ............................
Speech & Language Delay .....
Thyroid Cancer .......................
Topics Recently Reviewed:
Abdominal Aortic Aneurysm ...
Adolescent Idiopathic Scoliosis
Alcohol Misuse ........................
Bladder Cancer .......................
BRCA 1 & 2 ............................
Breastfeeding ..........................
Cervical Cancer ......................
Coronary Heart Disease
screening by EKG, ETT,
EBCT.
Dementia .................................
Dental Caries in Preschool
Children.
Diabetes Mellitus Type 2 ........
Family Violence .......................
Genital Herpes Simplex ..........
Glaucoma ................................
Gonorrhea ...............................
Hepatitis B Virus Infection ......
Hepatitis C Virus Infection in
Adults.
Healthy Diet ............................
HIV Infection ...........................
Hypertension ...........................
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
S
PM
PM
PM
S
S/PM
S
S
S
S
S
S
S
S
S
S
S
C
S
S
C
S/C
S
S/C
S
S
S
S
C
S
S
C
S
S
S
S
S
S
S
S
S
S
S
C
S
S
Type of
preventive
service
Low Back Pain ........................
Lung Cancer ...........................
Obesity in Children .................
Oral Cancer .............................
Ovarian Cancer .......................
Pancreatic Cancer ..................
Peripheral Arterial/Vascular
Disease.
Physical Activity ......................
Postmenopausal Hormone
Prophylaxis (HRT).
Prostate Cancer ......................
Rh Incompatibility ....................
Suicide Risk ............................
Syphilis ....................................
Testicular Cancer ....................
Thyroid Disease ......................
Visual Impairment in Children
C
S
S
S
S
S
S
C
PM
S
S
S
S
S
S
S
Type of Preventive Service: S = Screening;
C = Counseling; PM = Preventive Medications.
Dated: January 17, 2006.
Carolyn M. Clancy,
Director.
[FR Doc. 06–612 Filed 1–23–06; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meetings
In accordance with section 10(d) of
the Federal Advisory Committee Act as
amended (5 U.S.C., Appendix 2), the
Agency for Healthcare Research and
Quality (AHRQ) announces meetings of
scientific peer review groups. The
subcommittees listed below are part of
the Agency’s Health Services Research
Initial Review Group Committee.
The subcommittee meetings will be
closed to the public in accordance with
the Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications are to be reviewed and
discussed at these meetings. These
discussions are likely to involve
information concerning individuals
associated with the applications,
including assessments of their personal
qualifications to conduct their proposed
projects. This information is exempt
from mandatory disclosure under the
above-cited statutes.
1. Name of Subcommittee: Health Care
Technology and Decision Sciences.
Date: February 2, 2006 (Open from 8
a.m. to 8:15 a.m. on February 2 and
closed for remainder of the
meeting).
E:\FR\FM\24JAN1.SGM
24JAN1
Federal Register / Vol. 71, No. 15 / Tuesday, January 24, 2006 / Notices
2. Name of Subcommittee: Health
Research Dissemination and
Implementation.
Date: February 16, 2006 (Open from 8
a.m. to 8:15 a.m. on February 16
and closed for remainder of the
meeting).
3. Name of Subcommittee: Health Care
Quality and Effectiveness Research.
Date: February 23, 2006 (Open from 8
a.m. to 8:15 a.m. on February 23
and closed for remainder of the
meeting).
4. Name of Subcommittee: Health
Research Training.
Date: February 27–28, 2006 (Open
from 9 a.m. to 9:15 a.m. on February
27 and closed for remainder of the
meeting).
5. Name of Subcommittee: Health
Systems Research.
Date: February 28, 2006 (Open from 9
a.m. to 9:15 a.m. on February 28
and closed for remainder of the
meeting).
All the meetings above will take place
at: Agency for Healthcare Research and
Quality, John Eisenberg Conference
Center, 540 Gaither Road, Rockville,
Maryland 20850.
Contact Person: Anyone wishing to
obtain a roster of members, agenda or
minutes of the nonconfidential portions
of the meetings should contact Mrs.
Bonnie Campbell, Committee
Management Officer, Office of
Extramural Research, Education and
Priority Populations, AHRQ, 540
Gaither Road, Suite 2000, Rockville,
Maryland 20850, Telephone (301) 427–
1554.
Agenda items for these meetings are
subject to change as priorities dictate.
This notice is being published less
than 15 days prior to the February 2
meeting, due to the time constraints of
reviews and funding cycles.
Dated: January 13, 2006.
Carolyn M. Clancy,
Director.
[FR Doc. 06–611 Filed 1–23–06; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
rmajette on PROD1PC67 with NOTICES1
[30Day–06–0576]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
VerDate Aug<31>2005
14:44 Jan 23, 2006
Jkt 208001
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–4766 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Possession, Use, and Transfer of
Select Agents and Toxins (OMB Control
No. 0920–0576)—Revision—Office of
the Director (OD), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002 (Pub. L. 107–188)
specifies that the Secretary of Health
and Human Services (HHS) shall
provide for the establishment and
enforcement of standards and
procedures governing the possession,
use, and transfer of select agents and
toxins that have the potential to pose a
severe threat to public health and safety.
The Act specifies that entities that
possess, use, and transfer these select
agents register with the HHS Secretary.
The HHS Secretary has designated CDC
as the agency responsible for collecting
this information.
CDC is requesting continued OMB
approval to collect this information
through the use of five separate forms.
These forms are: (1) Application for
Registration, (2) Request to Transfer
Select Agent or Toxin, (3) Report of
Theft, Loss, or Release of Select Agent
and Toxin, (4) Report of Identification of
Select Agent or Toxin, and (5) Request
for Exemption.
The Application for Registration (42
CFR, 73.7(d)) is used by entities to
register with CDC. The Application for
Registration requests facility
information; a list of select agents or
toxins in use, possession, or for transfer
by the entity; characterization of the
select agent or toxin; and laboratory
information. Estimated average time to
complete this form is 3 hours, 45
minutes for an entity with one principal
investigator working with one select
agent or toxin. CDC estimates that
entities will need an additional 45
minutes for each additional investigator
or agent. In our regulatory analysis, we
have estimated that 70% of the 350
entities have 1–3 principal investigators,
15% have 5 principal investigators, and
15% have 10 principal investigators. We
have used these figures to calculate the
burden for this section. Estimated
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
3851
burden for the Application for
Registration is 2,191 hours.
Entities may amend their registration
(42 CFR, 73.7(h)(1)) if any changes occur
in the information submitted to CDC. To
apply for an amendment to a certificate
of registration, an entity must obtain the
relevant portion of the application
package and submit the information
requested in the package to CDC.
Estimated time to amend a registration
package is 1 hour.
The Request to Transfer Select Agent
or Toxin form (42 CFR 73.16) is used by
entities requesting transfer of a select
agent or toxin to their facility and by the
entity transferring the agent. CDC
revised the Request to Transfer Select
Agent or Toxin form by removing the
requirement that entities provide
written notice within five business days
when select agents or toxins are
consumed or destroyed after a transfer.
Estimated average time to complete this
form is 1 hour, 30 minutes.
The Report of Theft, Loss, or Release
of Select Agent and Toxin form (42 CFR
73.19(a)(b)) must be completed by
entities whenever there is theft, loss, or
release of a select agent or toxin.
Estimated average time to complete this
form is 1 hour.
The Report of Identification of Select
Agent or Toxin form 42 CFR 73.5(a)(b)
and 73.6(a)(b)) is used by clinical and
diagnostic laboratories to notify CDC
that select agents or toxins identified as
the result of diagnostic or proficiency
testing have been disposed of in a
proper manner. In addition, the form is
used by Federal law enforcement
agencies to report the seizure and final
disposition of select agents and toxins.
Estimated average time to complete this
form is 1 hour.
The Request for Exemption form (42
CFR 73.5 (d)(e) and 73.6 (d)(e)) is used
by entities that are using an
investigational product that are, bear, or
contain select agents or toxins or in
cases of public health emergency.
Estimated average time to complete this
form is 1 hour.
In addition to the standardized forms,
this regulation also outlines situations
in which an entity must notify or may
make a request of the HHS Secretary in
writing. An entity may apply to the HHS
Secretary for an expedited review of an
individual by the Attorney General (42
CFR 73.10(e)). To apply for this
expedited review, an entity must submit
a request in writing to the HHS
Secretary establishing the need for such
action. The estimated time to gather the
information and submit this request is
30 minutes. CDC has not developed
standardized forms to use in the above
situations. Rather, the entity should
E:\FR\FM\24JAN1.SGM
24JAN1
]]>Agencies
[Federal Register Volume 71, Number 15 (Tuesday, January 24, 2006)]
[Notices]
[Pages 3850-3851]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-611]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meetings
In accordance with section 10(d) of the Federal Advisory Committee
Act as amended (5 U.S.C., Appendix 2), the Agency for Healthcare
Research and Quality (AHRQ) announces meetings of scientific peer
review groups. The subcommittees listed below are part of the Agency's
Health Services Research Initial Review Group Committee.
The subcommittee meetings will be closed to the public in
accordance with the Federal Advisory Committee Act, section 10(d) of 5
U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications are to
be reviewed and discussed at these meetings. These discussions are
likely to involve information concerning individuals associated with
the applications, including assessments of their personal
qualifications to conduct their proposed projects. This information is
exempt from mandatory disclosure under the above-cited statutes.
1. Name of Subcommittee: Health Care Technology and Decision Sciences.
Date: February 2, 2006 (Open from 8 a.m. to 8:15 a.m. on February 2
and closed for remainder of the meeting).
[[Page 3851]]
2. Name of Subcommittee: Health Research Dissemination and
Implementation.
Date: February 16, 2006 (Open from 8 a.m. to 8:15 a.m. on February
16 and closed for remainder of the meeting).
3. Name of Subcommittee: Health Care Quality and Effectiveness
Research.
Date: February 23, 2006 (Open from 8 a.m. to 8:15 a.m. on February
23 and closed for remainder of the meeting).
4. Name of Subcommittee: Health Research Training.
Date: February 27-28, 2006 (Open from 9 a.m. to 9:15 a.m. on
February 27 and closed for remainder of the meeting).
5. Name of Subcommittee: Health Systems Research.
Date: February 28, 2006 (Open from 9 a.m. to 9:15 a.m. on February
28 and closed for remainder of the meeting).
All the meetings above will take place at: Agency for Healthcare
Research and Quality, John Eisenberg Conference Center, 540 Gaither
Road, Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the nonconfidential portions of the meetings
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Suite 2000, Rockville, Maryland 20850,
Telephone (301) 427-1554.
Agenda items for these meetings are subject to change as priorities
dictate.
This notice is being published less than 15 days prior to the
February 2 meeting, due to the time constraints of reviews and funding
cycles.
Dated: January 13, 2006.
Carolyn M. Clancy,
Director.
[FR Doc. 06-611 Filed 1-23-06; 8:45 am]
BILLING CODE 4160-90-M
